Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
DRUG compared with LLY: revenue, margins and what each company keeps, and the suppliers and customers both name
DRUG
Bright Minds Biosciences Inc.
Change
Mkt cap
Revenue
Revenue
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
vs
Compare
DRUG
Bright Minds Biosciences Inc.
vs
LLY
ELI Lilly & Co
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Co-movers
Desk
News
Calendar
Saved
Search
Co-movers
daily closes
Method
›
Moved together
DRUG
with
LLY
Inverse: r -0.03 · 500D.
No shared co-movers.
DRUG, solid
LLY, hatched
r = correlation
Bar = r to r 0.75
Source: daily closes
DRUG
Bright Minds Biosciences Inc.
Change
22.87
▲
+10.48%
· post 22.66
· delayed
Mkt cap
$158.1M
Revenue
—
Revenue
—
LLY
ELI Lilly & Co
Change
1,360.90
▼
−0.28%
· post 1,354.07
· delayed
After hours
Nov 6 '26
delayed
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
vs
Compare
After hours
Nov 6 '26
delayed
DRUG
Bright Minds Biosciences Inc.
vs
LLY
ELI Lilly & Co
22.87
▲
+10.48%
post 22.66
delayed
Price
1,360.90
▼
−0.28%
post 1,354.07
delayed
$158.1M
Mkt cap
$1.2T
—
Revenue
$24.4B
Q3 FY26
—
Revenue
$65.2B
FY25
Change
Change
DRUG
22.87
▲
+10.48%
vs
LLY
1,360.90
▼
−0.28%
After hours
Nov 6 '26
delayed